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Primary Hyperparathyroidism in Patients with Multiple Endocrine
Neoplasia Type 1: Experience by a Single Surgical Team in Japan

Takao Obara,* Yoshihide Fujimoto,* and Yukio Ito*

Nineteen patients were surgically treated for hyperparathyroidism associated with multiple
endocrine neoplasia type 1 syndrome. Fourteen patients (74%) had removal of three or more
parathyroid glands at the first operation, and five (26%) by removal of 2'/2 or fewer glands. Two
patients had recurrent hypercalcemia during the mean follow-up period of 65 months. One had a
recurrence 10 years after subtotal parathyroidectomy. Reexploration in this patient revealed
enlargement of the remaining tissue in the neck and an enlarged supernumerary gland in the
aorticopulmonary window. The other patient had persistent hypercalcemia after removal of two
hyperplastic parathyroid glands until after another I 'h more glands were removed. After reoperation
the patient was normocalcemic for 10 years before hypercalcemia was again noticed. The patient
subsequently died from renal carcinoma metastases, which might have been the cause of the
hypercalcemia before death. (Henry Ford Hosp MedJ 1992:40:191-4)

I

n the hyperparathyroidism (HPT) associated with multiple
endocrine neoplasia type I (MEN 1) syndrome, chief cell hyperplasia is found in all of the parathyroid glands. Recurrent or
persistent HPT occurs at a high rate after parathyroidectomy in
patients with MEN 1(1). Removal of fewer than three parathyroid glands at the initial operation has resulted in a high incidence of recurrence (1-6). The most effective treatment is either
subtotal parathyroidectomy or total parathyroidectomy with autotransplantation with the identification ofall four glands at the
initial operation, although supemumerary hyperplastic parathyroid glands occasionally cause recurrent or persistent hyperparathyroidism (7). On rare occasions, some type of malignant
tumor may be a source of hypercalcemia in patients with MEN 1
(8). We report the outcome of parathyroid surgery in our series
of MEN 1 patients with special reference to uncommon causes
of recurrent hypercalcemia.

Patients and Methods
From 1968 through 1990, 363 patients with verified primary
HPT had their first parathyroid surgery performed by us.
Twenty patients (5.5%) had HPT as part of the MEN 1 syndrome. Nineteen were from 10 families with verified MEN 1
and the other had no known relatives with the syndrome. Patients included 10 males and 10 females, with an age range of 22
to 73 years (mean 46 years).
The patients have been followed for 8 to 171 months (mean
65 months) after the initial operation. The information collected
included operative procedures for parathyroid disease and data
from pathological reports and clinical records including associated disorders and the current serum calcium (Ca) levels. The
clinical and autopsy records of a patient who died during the follow-up period were evaluated. Eleven patients were followed by
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us and eight by physicians at other institutions. In patients followed by others, hypercalcemia or hypocalcemia refers to levels
of serum Ca outside the normal range established in each laboratory. One patient who underwent subtotal parathyroidectomy in
1976 was excluded from the study because clinical information
or the current serum Ca level data were not available, although
he was stated to be "healthy."
Surgical procedures were classified as 2'/2 glands or fewer removed or three glands or more removed. Removal of three or
more glands included either subtotal (3'/2 glands) parathyroidectomy or total parathyroidectomy with autograft of a portion
of the gland into a muscle or subcutaneous tissue. Excision of
three glands and autotransplantation along with partial thyroidectomy, total thyrnectomy through median sternotomy, or cervical thymectomy for a missing fourth gland were included in the
latter group.

Results
Associated features of the M E N 1 syndrome
A growth hormone-producing pituitary tumor preceded HPT
in one patient and prolactin-producing pituitary adenomas and
HPT were simultaneously diagnosed in two patients. Two other
patients were found to have prolactinomas 10 and 11 years after
the initial parathyroidectomy. In another patient, autopsy revealed clinically asymptomatic microadenomas of the pituitary
gland. On immunohistologic examination, the microadenomas
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Fig I—SPECT scan with thallium of case I (sagittal view)
demonstrating increased activity (arrow) in the middle mediastinum.

stained for adrenocorticotrophic hormone (ACTH) and prolactin. In total, six of the 19 patients (32%) had pituitary tumors
associated with HPT.
Endocrine pancreatic tumors were histologically verified in
two patients and suspected from hormone levels and the clinical
course in three others. Clinically, two of the patients had verified and one had suspicious Zollinger-Ellison (ZE) syndrome.
Another patient had the ZE syndrome combined with hypoglycemia. In one patient, asymptomatic islet cell tumors were
found at autopsy.
Other associated features found in one patient each included
renal carcinoma, bronchial carcinoid tumors and pelvic sarcoma, thymic carcinoid tumor, papillary thyroid carcinoma,
gastric carcinoid tumor and thymoma, and nonfunctioning cortical adenoma of the adrenal. Five of the 19 patients (26%) had
malignant lesions outside of the pancreas with the diagnosis established concomitandy with the HPT in two patients and subsequently to the HPT in three patients. Bronchial carcinoid, renal
carcinoma, or ga.stric carcinoid developed in each of the latter
three patients. The intervals between the initial parathyroidectomy and the diagnosis of these tumors were 11,9, and 5 years,
respectively.
Outcome of parathyroidectomy
Fourteen patients (74%) were treated by removal of three or
more parathyroid glands as the initial surgical procedure, and
five (26%) by removal of 2'/2 or fewer glands. In the latter five
patients, the surgeons thought that the procedure was appropriate because the other two parathyroid glands were of normal size
or were not identified despite meticulous search. After resection
of 2 to 2V2 glands, four patients were normocalcemic at followup of 1 to 6 years (mean 3.8 years). None of the patients required
vitamin D or Ca substitution postoperatively. One of these five
patients had persistent HPT requiring reoperation (resection of
the remaining 1 '/2 glands).
Among the 14 patients in whom three or more glands were removed at the initial operation and one patient who had a subsequent reoperation, subtotal parathyroidectomy was pertbrmed
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Fig 2—Computed tomography scan of case 1 disclosing the abnormal tumor (arrow) in the aorticopulmonary window.

in nine and total parathyroidectomy with autotransplantation in
six patients. Only one of the nine patients undergoing subtotal
parathyroidectomy required substitution of vitamin D and/or
oral Ca for eight months, while all the patients receiving total
parathyroidectomy and transplantation required medication
postoperatively. Eight of the patients became normocalcemic
later without medication 3 to 16 months after the operation, although one patient required permanent supplemental medication.
Twelve patients have had normal serum Ca levels for 0.8 to
10.8 years (mean 5.0 years), while in two patients hypercalcemia recurred 9.4 and 10.8 years after the exploration. Both pre.sented unusual features of recurrence.

Case Reports
Casel
A 33-year-old woman with primary HPT and recurrent renal stones
underwent subtotal parathyroidectomy for primary parathyroid hyperplasia and had i-ernained normocalcemic for 10 years. Nevertheless, hypercalcemia recurred accompanied by the amenoi-rhea-galactorrhea
syndroine. peptic ulcer diathesis, and hypoglycemic symptoms. Hyperprolactinemia and detection of a pituitai-y lumor by cornputed tomography and magnetic resonance imaging led to a definite diagnosis of
pi-olactinoma. Both a gastrinoma and an insulinoma of the pancreas,
which had been confirmed by hormone measurements and preoperative
localization studies, were removed. The neck was reexplored and an
enlarged hyperplastic parathyroid gland removed; a portion of the
gland was autografted in the forearm muscle. However, the patient reinained persistendy hypercalcemic (the serum Ca level was 11 to 12
mg/dL). Localization .studies including thallium scanning and computed tomography suggested the presence of a parathyroid gland it-i the
anterior mediastinum. Mediastinal exploration failed to locate an abnormal parathyroid gland in the thymus or anterior mediasdnal fat tissue. Further investigations were made to locate a missing supemumerary parathyroid gland. Eventually, single photon emission computed
tomography (SPECT) using thallium demonstrated increased activity
in the rnid mediastinum (Fig 1), and coi-nputed ton-iography revealed
the presence of a tumor in the aorticopulmonary window (Fig 2). At exploration of the mid mediastinum through a right thoracotomy, a hyper-
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plastic parathyroid gland was successfully excised. Postoperatively the
patient has remained normocalcemic without supplementation. The
concentration of parathyroid hormone (PTH) in the antecubital vein of
the grafted arm was 17 times that in the nongrafted arm.

Case 2
A 56-year-old man. father of the patient in case 1, underwent initial
cervical exploration for primary HPT in which two hyperplastic parathyroid glands weighing 1.2 g and 0.5 g were removed. The serum Ca
level remained normal for two months but hypercalcemia recurred. At
a second cervical exploration the two remaining hyperplastic parathyroid glands were removed leaving approximately 60 mg in one gland.
This procedure rendered the patient normocalcemic for a nine-year follow-up period when he complained of right epigastric pain, and ultrasonography and coiTiputed tomography disclosed a large right abdominal tumoi-. The tumor was a renal carcinoma, stage IV. Simultaneously,
recurrent hypercalcemia (11.2 to 12.0 mg/dL) was noted. The serum CPTH level was less than 0.1 ng/mL (normal level less than 0.3 ng/mL),
and chemotherapy along with administration of prednisolone reduced
the serum Ca level. The patient later died of the metastatic renal carcinoma; at autopsy tumorous lesions min-iicking hypeiplastic parathyroid
glands were found around the thyroid gland which were meta.sta.ses of
renal carcinoma, with the remaining pai-athyt-oid gland totally involved
with metastatic tumor cells. However, a tiny supemumerary hyperplastic parathyroid gland was found in the neck. The pituitary gland contained microadenomas which stained immunohistologically for ACTH
and prolactin. The pancreas coi-itained small islet cell tumors associated
with islet hyperplasia.

Discussion
Involvement of more than one and perhaps invariably of all
(four or more) parathyroid glands is the characteristic feature of
HPT in MEN 1. Rizzoli et al (1) substantiated this observation
with an unusually high failure rate for parathyroidectomy for
primary HPT in patients with MEN 1. The ideal surgical strategy for primary HPT in patients with MEN 1 remains controversial. Some authors have continued to recommend subtotal
parathyroidectomy (2,3,9), while others advocate total parathyroidectomy (4,10,11). In the present series, only two of the 19
patients have had documented recurrence of hypercalcemia.
Persistent HPT was avoidable in one ofthe five patients who underwent removal of only two enlarged glands at the initial operation. Despite removal of only two glands, four patients have remained normocalcemic to date. Since the mean time of followup is only four years, additional recurrence inay be observed
later and further follow-up is warranted.
None of the six patients who underwent total parathyroidectomy with autotransplantation has had a recurrence to date, but
one (17%) became permanently hypocalcemic. Graft-dependent
hypercalcemia was not seen. Among the eight patients who underwent subtotal parathyroidectomy at the initial exploration,
none developed permanent hypoparathyroidism, but one patient
(12.5%) had recurrent HPT. In the patient presented as case 1,
however, the removal of four glands and parathyroid autotransplantation at the initial operation would not have been curative
since an aberrant fifth gland was the cause of persistent hypercalcemia after the second exploration. Therefore, our view is
that the treatment of choice in patients with the MEN 1 syn-
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drome and HPT rests between subtotal and total (with autograft)
parathyroidectomy.
A functioning supemumerary parathyroid gland is rare. Most
are located in the anterior mediastinum closely related to the
thymus (7). Nevertheless, several authors reported cases of supemumerary hyperfunctioning parathyroid glands (12-15). To
the best of our knowledge, only two patients with MEN 1 syndrome and supemumerary hyperplastic parathyroid gland at this
site have been reported, including our case 1 (12). Preoperative
localization of the ectopic lesion is difficult. In our experience,
SPECT using thallium chloride is useful for detecting a lesion in
the mid mediastinum (15).
In the patient (case 2) who underwent subtotal parathyroidectomy at reexploration, recurrent hypercalcemia occurred in conjunction with metastatic renal carcinoma. Although an association of M E N 1 syndrome with renal carcinoma has been reported previously (2), this is probably coincidental. However, it
should be noted that renal carcinoma is often associated with hypercalcemia with a reported incidence as high as 16.8% (16).
Most of the patients with hypercalcemia caused by renal cell
carcinoma presented with advanced disease. We believe the patient in case 2 had humoral hypercalcemia of malignancy caused
by renal carcinoma with metastases. It is unlikely that the remnant of parathyroid tissue left at the second exploration was hyperfunctioning because the supemumerary parathyroid gland
found at autopsy was small and presumably the gland partially
resected at the second exploration was totally involved by the
carcinoma.
Parathyroid hormone-related protein (PTHrP) has been invoked as a cause of humoral hypercalcemia of malignancy (17).
PTHrP messenger RNA has been identified by in situ hybridization in tumors associated with hypercalcemia, such as bronchial
carcinoid, malignant pheochromocytoma, squamous cell lung
cancer, hepatocellular carcinoma, malignant islet cell tumor, renal carcinoma, and breast cancer (18,19).
Of note is that carcinoid tumors and islet cell tumors are components of MEN 1. Various other endocrine or nonendocrine
malignancies are occasionally associated with primary HPT
(20). In the present series, three patients (16%) had carcinoid tumors and three had various carcinomas. The diagnosis of MEN
1 requires a close follow-up of the identified patient and close
relatives.
In conclusion, surgeons should be aware that recurrence of
hypercalcemia in MEN 1 may require a search for an ectopically
located fifth parathyroid gland or for an associated malignancy,
particularly in MEN 1 patients who have had subtotal or total
parathyroidectomies.

References
1. Rizzoli R, Green J III, Marx SJ. Primary hyperparathyroidism in familial
multiple endocrine neoplasia type I: Long-term follow-up of serum calcium levels after parathyroidectomy. Am J Med 1985;78:467-74.
2. Scholz DA, Pumell DC, Edis AJ, van Heerden JA, Woolner LB, Primary
hyperparathyroidism with multiple parathyroid gland enlargement: Review of
5.3 cases. Mayo Clin Proc 1978;53:792-7.
3. van Heerden JA. Kent RB III. Sizemore GW, Grant CS, ReMine WH. Priniary hypeiparathyroidism in patients with multiple endocrine neoplasia syndromes: Surgical experience. Arch Surg 1983;118:533-6.

Unusual Recurrent Hypercalcemia in MEN 1—Obara et al 193

4. Malmaeus J, Benson L, Johansson H, et al. Parathyroid surgery in the multiple endocrine neoplasia type I syndrome: Choice of surgical procedure. Worid J
Surg 1986;10:668-72.
5. Oberg K. Skogseid B, Eriksson B. Multiple endocrine neoplasia type 1
(MEN-1): Clinical, biochemical and genetical investigations. Acta Oncol
1989;28;383-7.
6. Samaan NA, Ouais S, Ordonez NG, Choksi UA, Sellin RV, Hickey RC.
Multiple endocrine syndrome type I: Clinical, laboratory findings, and management in five families. Cancer 1989;64:741-52.
7. Rus.sell CF, Grant CS, van Heerden JA. Hyperfunctioning supernumerary
parathyroid glands: An occasional cause of hyperparathyroidism. Mayo Clin
Proc 1982;57:121-4.
8. Yamaguchi K, KameyaT, Abe K. Multiple endocrine neoplasia type I.Clin
Endocrinol Metab 1980;9:261-84.
9. Thompson NW. The techniques of initial parathyroid exploration and reoperative parathyroidectomy. In: Thompson N, Vinik AI, eds. Endocrine surgery update. New York: Grune & Stratton, 1983:365-83.
10. Wells SA Jr, Famdon JA, Dale JK, Leight GS, Dilley WG. Long-term
evaluation of patients with primary parathyroid hyperplasia managed by total
parathyroidectomy and heterotopic autotransplantation. Ann Surg 1980; 192:
451-8.
11. Prinz RA. Gamvros OI. Sellu D. Lynn JA. Subtotal parathyroidectomy for
primary chief cell hyperplasia of the multiple endocrine neoplasia type I syndrome. Ann Surg 1981;193:26-9.

194

Henry Ford Hosp Med J—Vol 40. Nos 3 & 4, 1992

12. Curley IR, Wheeler MH, Thoinpson NW, Grant CS. The challenge of the
middle mediastinal parathyroid. World J Surg 1988;12:818-24.
13. McHenry C, Walsh M, Jarosz H, et al. Resection of parathyroid tumor in
the aorticopulmonary window without prior neck exploration. Surgery 1988;
104:1090-4.
14. Proye C, Lefebvre J, Bourdelle-Hego M-F, et al. Middle mediastinal parathyroid adenoma of the aorto-pult-nonary window, 2 cases. Chirurgie 1988;
114:166-73.
15. Obara T. Fujimoto Y Tanaka R, et al. Mid-mediastinal parathyroid lesions: Preoperative localization and surgical approach in two cases. Jpn J Surg
1990;20;48I-6.
16. Chasan SA. Pothel LR. Huben RP. Management and prognostic significance of hypercalcemia in renal cell carcinoma. Urology 1989;33:16770.
17. Martin TJ, Danks JA, A novel parathyroid hormone-related gene product.
Henry Ford Hosp Med J 1989;37:187-9.
18. Heath DA, Senior PV, Varley JM, Beck F. Parathyroid-hormone-related
protein in tumours associated with hypercalcaemia. Lancet 1990;335:66-9.
19. Rizzoli R, Sappino AP, Bonjour J-P. Parathyroid hormone-related protein
and hypercalcemia in pancreatic neuro-endocrine tumors. Int J Cancer
1990;46:394-8.
20. Wajngot A. Werner S. Granberg P-O. Lindvall N. Occurtence of pituitary
adenomas and other neoplastic diseases in primary hyperparathyroidism. Surg
Gynecol Obstet 1980;151:401-3.

Unusual Recurrent Hypercalcemia in MEN I—Obara et al

